Zimmer Discontinued Operations from 2010 to 2024
| ZBH Stock | USD 114.04 0.92 0.81% |
Discontinued Operations | First Reported 2000-03-31 | Previous Quarter 4.7 M | Current Value 4.7 M | Quarterly Volatility 1 M |
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 526 M, Interest Expense of 134.7 M or Selling General Administrative of 2 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0157 or PTB Ratio of 1.93. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
Zimmer | Discontinued Operations |
Latest Zimmer Biomet's Discontinued Operations Growth Pattern
Below is the plot of the Discontinued Operations of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Discontinued Operations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
| Discontinued Operations | 10 Years Trend |
|
Discontinued Operations |
| Timeline |
Zimmer Discontinued Operations Regression Statistics
| Arithmetic Mean | (110,068,067) | |
| Coefficient Of Variation | (28.75) | |
| Mean Deviation | 26,593,502 | |
| Median | (128,200,000) | |
| Standard Deviation | 31,642,599 | |
| Sample Variance | 1001.3T | |
| Range | 84.8M | |
| R-Value | 0.73 | |
| Mean Square Error | 500.6T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 5,178,832 | |
| Total Sum of Squares | 14017.6T |
Zimmer Discontinued Operations History
About Zimmer Biomet Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Zimmer Biomet income statement, its balance sheet, and the statement of cash flows. Zimmer Biomet investors use historical funamental indicators, such as Zimmer Biomet's Discontinued Operations, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet investors may use each financial statement separately, they are all related. The changes in Zimmer Biomet's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zimmer Biomet's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Zimmer Biomet Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Zimmer Biomet. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Discontinued Operations | -67.6 M | -71 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zimmer Stock
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out the analysis of Zimmer Biomet Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 0.96 | Earnings Share 4.61 | Revenue Per Share 35.889 | Quarterly Revenue Growth 0.032 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.